Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • dcameron
    Member
    • Mar 2013
    • 27

    #1

    Introducing GRIDSS: the Genomic Rearrangement IDentification Software Suite

    GRIDSS is typically used for detecting structural variation breakpoints but is a modular software suite containing a number of tools useful for the detection of genomic rearrangements. Whilst nowhere near as extensive as BBTools, this suite includes:

    - A structural variant caller.
    The GRIDSS caller uses break-end assembly, split read, and read pair evidence to call variants.
    - A genome-wide break-end assembler. Assembles all break-end contigs without resorted to targeted or windowed assembly.
    - A read extractor.
    Supports extraction of any subset of indel-containing reads, soft/(hard)-clipped reads, split reads, discordant read pairs, read pairs with only one read mapped and unmapped reads in a single step.
    - A split read identifier. This tools converts soft-clipped reads to split reads using the standard SA SAM tag. As it output split read alignments using the standard SA tag, it can also be used to remove the dependency on bwa alignment for tools such as LUMPY and Wham.

    GRIDSS has been extensively tested across a wide range read depths, read lengths and library fragment sizes. Except for reads shorter that 50bp and coverage under ~10x, GRIDSS outperforms existing SV callers. On 50x 2x100bp human cell line WGS data, GRIDSS achieve false discovery rate half that of BreakDancer, CREST, DELLY, HYDRA, LUMPY, Manta, Pindel, and Socrates with no loss of sensitivity. Benchmarking results are available at http://shiny.wehi.edu.au/cameron.d/sv_benchmark/.

    The GRIDSS preprint is available at http://biorxiv.org/content/early/2017/02/21/110387.

    GRIDSS is free and open source software and is available at https://github.com/PapenfussLab/gridss/.

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 11:13 AM
0 responses
21 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, Yesterday, 10:48 AM
0 responses
18 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Working...